Lv2
150 积分 2025-04-18 加入
Small molecule drug absorption in inflammatory bowel disease and current implementation in physiologically- based pharmacokinetic models
1个月前
已完结
PBPK Modeling as an Alternative Method of Interspecies Extrapolationthat Reduces the Use of Animals: A Systematic Review
1个月前
已完结
Gastrointestinal Bile Salt Concentrations in Healthy Adults Under Fasted and Fed Conditions: A Systematic Review and Meta-Analysis for Mechanistic Physiologically-Based Pharmacokinetic (PBPK) Modelling
1个月前
已完结
Physiologically based pharmacokinetic (PBPK) modeling of BDE-209 following oral exposure in Chinese population
1个月前
已完结
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib
2个月前
已完结
Development and validation of a sensitive LC-MS/MS assay for determination of upadacitinib in human plasma and its application in patients with inflammatory bowel disease
2个月前
已完结
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis
4个月前
已完结
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects
4个月前
已完结
The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism
4个月前
已完结
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis
4个月前
已完结
皖公网安备34019202002308
